Christopher J Kirk Selected Research

Christopher J Kirk Research Topics

Disease

16	Neoplasms (Cancer) 03/2024 - 07/2007
13	Multiple Myeloma 10/2021 - 07/2007
4	Rheumatoid Arthritis 01/2023 - 07/2009
4	Colitis 12/2018 - 07/2010
4	Disease Progression 09/2015 - 02/2012
3	Autoimmune Diseases (Autoimmune Disease) 12/2018 - 09/2008
3	Squamous Cell Carcinoma of Head and Neck 09/2014 - 10/2012
3	Leukemia 05/2014 - 12/2013
3	Hematologic Neoplasms (Hematological Malignancy) 05/2014 - 07/2007
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023 - 09/2015
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2018 - 01/2014
2	Inflammation (Inflammations) 01/2014 - 07/2010
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2009 - 07/2007
1	Proteinuria 01/2023
1	Lupus Nephritis 01/2023
1	Muscle Weakness 01/2022
1	Polymyositis 01/2022
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2022
1	Glucocorticoid Receptor Deficiency 01/2022
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2022
1	Chronic Disease (Chronic Diseases) 10/2021
1	Plasma Cell Neoplasms 10/2021
1	Encephalomyelitis (Myeloencephalitis) 09/2015
1	Graft vs Host Disease (Graft-Versus-Host Disease) 09/2015
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2013
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2013
1	Alzheimer Disease (Alzheimer's Disease) 05/2013
1	Neuroinflammatory Diseases 05/2013
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2013
1	Arthritis (Polyarthritis) 10/2012
1	Head and Neck Neoplasms (Head and Neck Cancer) 10/2012
1	Nephritis 02/2012
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2012
1	Infections 12/2011
1	Peripheral Nervous System Diseases (PNS Diseases) 05/2011
1	Adenocarcinoma 01/2011
1	Weight Loss (Weight Reduction) 07/2010
1	Experimental Arthritis 07/2009

Drug/Important Bio-Agent (IBA)

15	Bortezomib (Velcade)FDA Link 10/2021 - 07/2007
13	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2021 - 07/2007
12	Proteasome InhibitorsIBA 09/2014 - 09/2008
11	carfilzomibIBA 10/2021 - 07/2007
9	PR-957IBA 01/2022 - 07/2009
7	CytokinesIBA 01/2023 - 07/2009
5	ONX 0912IBA 09/2014 - 12/2010
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2008
3	Peptides (Polypeptides)IBA 10/2021 - 07/2012
2	KZR-616IBA 01/2023 - 01/2022
2	GlucocorticoidsIBA 01/2022 - 12/2013
2	AutoantibodiesIBA 02/2012 - 07/2009
1	ErbB Receptors (EGF Receptor)IBA 03/2024
1	cotransinIBA 03/2024
1	Oncogene Proteins (Oncogene Protein)IBA 03/2024
1	SEC Translocation ChannelsIBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Epoxide HydrolasesIBA 10/2021
1	Boronic AcidsIBA 10/2021
1	ixazomibIBA 10/2021
1	Interleukin-6 (Interleukin 6)IBA 12/2018
1	Histocompatibility Antigens (Histocompatibility Antigen)IBA 09/2015
1	Histone Deacetylase InhibitorsIBA 09/2014
1	antineoplaston A10 (A 10)IBA 05/2014
1	InterferonsIBA 01/2014
1	Indicators and Reagents (Reagents)IBA 12/2013
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2013
1	Amyloid (Amyloid Fibrils)IBA 05/2013
1	Rituximab (Mabthera)FDA Link 01/2013
1	Dextrans (Dextran)FDA Link 10/2012
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 10/2012
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 04/2012
1	Adenosine Triphosphate (ATP)IBA 04/2012
1	Antirheumatic Agents (DMARD)IBA 04/2012
1	Multidrug Resistance-Associated ProteinsIBA 04/2012
1	EpitopesIBA 12/2011
1	DipeptidesIBA 05/2011
1	EndopeptidasesIBA 07/2010
1	Dextran SulfateIBA 07/2010
1	FlavonoidsIBA 12/2008
1	Peptide Hydrolases (Proteases)FDA Link 09/2008

Therapy/Procedure

4	Therapeutics 01/2022 - 12/2010
2	Oral Administration 10/2012 - 05/2009